MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 69 filers reported holding MEDTECH ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $49,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hartree Partners, LP | 1,730,000 | $17,178,900,000 | 4.26% |
| MYDA Advisors LLC | 403,070 | $4,002,000 | 1.12% |
| SPRING CREEK CAPITAL LLC | 503,600 | $5,001,000 | 0.24% |
| Omni Partners US LLC | 466,196 | $4,629,000 | 0.24% |
| BERKLEY W R CORP | 346,185 | $3,438,000 | 0.23% |
| ARISTEIA CAPITAL, L.L.C. | 1,153,485 | $11,454,000 | 0.21% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 146,388 | $1,454,000 | 0.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,999 | $9,930,000 | 0.19% |
| Magnetar Financial LLC | 1,743,417 | $17,312,000 | 0.18% |
| Context Capital Management, LLC | 174,065 | $1,728,000 | 0.18% |